| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.3 | 4e-25 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-15 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.31 | 1e-10 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-09 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |